Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement
Open accessPublished version of a preprint
The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
Breakthrough invasive fungal infections (bIFI) cause significant morbidity and mortality. Their diagnosis can be challenging due to reduced sensitivity to conventional culture techniques, serologic tests, and PCR-based assays in patients undergoing antifungal therapy, and their diagnosis can be delayed contributing to poor patient outcomes. In this review, we provide consensus recommendations on behalf of the European Confederation for Medical Mycology (ECMM) for the diagnosis of bIFI caused by invasive yeasts, molds, and endemic mycoses, to guide diagnostic efforts in patients receiving antifungals and support the design of future clinical trials in the field of clinical mycology. The cornerstone of lab-based diagnosis of breakthrough infections for yeast and endemic mycoses remain conventional culture, to accurately identify the causative pathogen and allow for antifungal susceptibility testing. The impact of non-culture-based methods are not well-studied for the definite diagnosis of breakthrough invasive yeast infections. Non-culture-based methods have an important role for the diagnosis of breakthrough invasive mold infections, in particular invasive aspergillosis, and a combination of testing involving conventional culture, antigen-based assays, and PCR-based assays should be considered. Multiple diagnostic modalities, including histopathology, culture, antibody, and/or antigen tests and occasionally PCR-based assays may be required to diagnose breakthrough endemic mycoses. A need exists for diagnostic tests that are effective, simple, cheap, and rapid to enable the diagnosis of bIFI in patients taking antifungals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donnelly, J. P., Chen, S. C., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1008 · Cited by 2,917
Self-citationCornely, O. A., Alastruey-Izquierdo, A., Arenz, D., Chen, S. C. A., Dannaoui, E., Hochhegger, B., Hoenigl, M., Jensen, H. E., Lagrou, K., Lewis, R. E., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30312-3 · Cited by 1,820
Self-citationUllmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationNeofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801 · cited 1×
“5% of patients with IA met the criteria for proven infection [53].”
BackgroundClinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 694 · cited 1×
“) [39] and the Biofire FilmArray BCID-FP (BioMérieux,”
MethodOstrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432470 · Cited by 669
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
Blot, S. I., Taccone, F. S., Van den Abeele, A.-M., Bulpa, P., Meersseman, W., Brusselaers, N., Dimopoulos, G., Paiva, J. A., Misset, B., Rello, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-1978oc · Cited by 628 · cited 1×
“To establish a diagnosis of “proven” invasive mold infection per consensus definitions by the European Organization for Research and Treatment of Cancer (EORTC) and the MSGERC [44] or the AspICU algorithm by Blot and colleagues [45], or other definitions for the ICU setting [46], histopathologic, cytopathologic, or di…”
Method-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
Intestinal fungi contribute to development of alcoholic liver disease
Yang, A.-M., Inamine, T., Hochrath, K., Chen, P., Wang, L., Llorente, C., Bluemel, S., Hartmann, P., Xu, J., Koyama, Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90562 · Cited by 464 · cited 1×
“Sensitivity and specificity for diagnosing invasive candidiasis are both around 80% [22,23], but false positive results have been described [24], in particular in conditions associated with fungal translocation in the gut such as sepsis or advanced liver cirrhosis [25,26].”
BackgroundVerweij, P. E., Rijnders, B. J. A., Brüggemann, R. J. M., Azoulay, E., Bassetti, M., Blot, S., Calandra, T., Clancy, C. J., Cornely, O. A., Chiller, T., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06091-6 · Cited by 459 · cited 1×
“To establish a diagnosis of “proven” invasive mold infection per consensus definitions by the European Organization for Research and Treatment of Cancer (EORTC) and the MSGERC [44] or the AspICU algorithm by Blot and colleagues [45], or other definitions for the ICU setting [46], histopathologic, cytopathologic, or di…”
MethodSelf-citation
Research works printed but not linked: 1
- WHO Guidelines Approved by the Guidelines Review Committee Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection World Health Organization Geneva, Switzerland 2018 30285342
Cited by
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs · doi:10.1007/s40265-021-01611-0 · Cited by 467
“The diagnosis of these breakthrough infections can be challenging even under optimal circumstances, owing to insufficient sensitivities of current diagnostics [6].”
BackgroundSelf-citationCadena, J., Thompson, G. R., & Patterson, T. F. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.008 · Cited by 234
Fungal infections diagnosis – Past, present and future
Mendonça, A., Santos, H., Franco‐Duarte, R., & Sampaio, P. (2021) · Research in Microbiology · doi:10.1016/j.resmic.2021.103915 · Cited by 144
Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches
Jenks, J. D., Nam, H. H., & Hoenigl, M. (2021) · Mycoses · doi:10.1111/myc.13274 · Cited by 140
Self-citationFungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
Thompson, G. R., Jenks, J. D., Baddley, J. W., Lewis, J. S., Egger, M., Schwartz, I. S., Boyer, J., Patterson, T. F., Chen, S. C. ‐., Pappas, P. G., et al. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-23 · Cited by 167
Self-citationSerology anno 2021—fungal infections: from invasive to chronic
Lass‐Flörl, C., Samardzic, E., & Knoll, M. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.02.005 · Cited by 123
Self-citationEpidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
Self-citationMicrobiological and Molecular Diagnosis of Mucormycosis: From Old to New
Lackner, N., Posch, W., & Lass‐Flörl, C. (2021) · Microorganisms · doi:10.3390/microorganisms9071518 · Cited by 77
“Bronchoalveolarlavage fluids and sinus tissue must be handled as sterile specimens [3].”
BackgroundSelf-citationSpecificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease
Finkelman, M. A. (2020) · Journal of Fungi · doi:10.3390/jof7010014 · Cited by 76
Singh, A., Singh, K., Sharma, A., Kaur, K., Chadha, R., & Bedi, P. M. S. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14266 · Cited by 71
“, 2017; Rawat & Shukla, 2016; Song et al., 2017). Zhao, Zhang, et al. (2017) designed a series of heterocyclic compounds inspired from the hydrogen bond interaction of voriconazole and lead Compound 32 with Tyr122 residue in the active site of 14alpha demethylase (CYP51B).”
BackgroundInfluentialPathogenic Drug Resistant Fungi: A Review of Mitigation Strategies
Garvey, M., & Rowan, N. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021584 · Cited by 69
Serapide, F., Pallone, R., Quirino, A., Marascio, N., Barreca, G. S., Davoli, C., Lionello, R., Matera, G., & Russo, A. (2025) · Diagnostics · doi:10.3390/diagnostics15081044 · Cited by 41
“Multiplex PCR assays have shown efficacy in identifying fungi such as Candida and Aspergillus , providing results faster than culture-based methods and enabling prompt initiation of antifungal therapy [38].”
Sahu, R. K., Salem-Bekhit, M. M., Bhattacharjee, B., Almoshari, Y., Ikbal, A. M. A., Alshamrani, M., Bharali, A., Salawi, A., Widyowati, R., Alshammari, A., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10091079 · Cited by 38
Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment
Heylen, J., Vanbiervliet, Y., Maertens, J. A., Rijnders, B. J. A., & Wauters, J. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1777769 · Cited by 41
“122 Speci fi city is improved in combination with GM or polymerase chain reaction (PCR).”
BackgroundChu, S., McCormick, T. S., Lazarus, H. M., Leal, L. O., & Ghannoum, M. A. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108731 · Cited by 32
Egger, M., Bellmann, R., Krause, R., Boyer, J., Jakšić, D., & Hoenigl, M. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s372546 · Cited by 31
Self-citationXu, H., Mou, Y., Guo, M., Zhang, R., Yan, Z.-Z., An, R., Wang, X., Su, X., Hou, Z., & Guo, C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114707 · Cited by 28
Monoclonal Antibodies and Invasive Aspergillosis: Diagnostic and Therapeutic Perspectives
Lian, X., Scott-Thomas, A., Lewis, J. G., Bhatia, M., MacPherson, S. A., Zeng, Y., & Chambers, S. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105563 · Cited by 27
Kanj, S. S., Omrani, A. S., Al-Abdely, H. M., Subhi, A. F., Fakih, R. O. E., Abosoudah, I. F., Kanj, H., & Dimοpoulos, G. (2022) · Journal of Fungi · doi:10.3390/jof8111146 · Cited by 21
Discovery of 1,2,3-selenadiazole analogues as antifungal agents using a scaffold hopping approach
Xu, H., Cao, C., Wang, X., Guo, M., Yan, Z.-Z., An, R., Zhang, R., Dong, E.-H., Mou, Y., Hou, Z., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105182 · Cited by 19
Kronig, I., Masouridi‐Levrat, S., Chalandon, Y., Glampedakis, E., Vernaz, N., van Delden, C., & Neofytos, D. (2021) · Mycopathologia · doi:10.1007/s11046-021-00583-9 · Cited by 17
Knoll, M. A., Lackner, N., Ulmer, H., Samardzic, E., Steinmann, J., Krause, R., Verhasselt, H. L., Rath, P., Fuchs, F., Koehler, P. A., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.04.014 · Cited by 12
Self-citationTio, S. Y., Neoh, C. F., Ritchie, D., Chee, L., Kong, D. C. M., Worth, L. J., Yong, M. K., & Slavin, M. A. (2025) · Transplant Infectious Disease · doi:10.1111/tid.70104 · Cited by 8
Wang, R., Jiang, A., Zhang, R., Shi, C., Ding, Q., Liu, S., Zhao, F., Ma, Y., Liu, J., Fu, X., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08447-x · Cited by 6
Meng, X., Liu, X., Li, L., Zheng, D., Zeng, L., Liu, Y., Li, R., Zhu, M., Cao, C., Cao, X., et al. (2025) · Mycopathologia · doi:10.1007/s11046-025-00940-y · Cited by 4
“For example, Mucorales, Scedosporium spp, Fusarium and dematiaceous fungi can be isolated, and the spectrum of pathogenic fungi is more extensive [4].”
Li, W., Zhu, H., Wen, L., Quan, M., & Wang, L. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7366432 · Cited by 3
RetractedHerrera, F., Torres, D., Méndez, G., Mañez, N., Jordán, R., Manzur, A., Cabral, M., Alderete, M., Allende, N., Benso, J. D., et al. (2025) · Journal of Fungi · doi:10.3390/jof11090648 · Cited by 2
“In this regard, the ECMM consensus status recommends the use of all available methods to diagnose bIFI [45].”
Rivas-Pinedo, P., & Oñate, J. (2026) · Journal of Fungi · doi:10.3390/jof12070498 · Cited by 4
A High-Speed Microscopy System Based on Deep Learning to Detect Yeast-Like Fungi Cells in Blood
Liu, R., Li, X., Liu, Y., Du, L., Zhu, Y., Wu, L., & Hu, B. H. (2024) · Bioanalysis · doi:10.4155/bio-2023-0193 · Cited by 2
Mutcalı, S. I., Hussain, N., Nematollahi, S., Lainhart, W., Zangeneh, T. T., & Al‐Obaidi, M. M. (2024) · Transplant Infectious Disease · doi:10.1111/tid.14327 · Cited by 2
“Theimaging should be accounted for, considering the lower sensitivity of respira-torycultureinidentifyingIPA,whichmighthaveledtomissedcases.”
InfluentialAgrawal, S. G., Bapat, A., Eades, C. P., & Gandhi, S. (2025) · eJHaem · doi:10.1002/jha2.1105 · Cited by 1
Singh, G. R., Azad, S., Kumari, M., Kumari, S., Kumar, S., & Ahmed, A. (2023) · Cureus · doi:10.7759/cureus.48925 · Cited by 1
Black Fungus Mutilating COVID-19 Pandemic in India: Facts and Immunological Perspectives
Mondal, A., Gireeshwar, M., & Lekha, G. (2022) · European Journal of Biology · doi:10.26650/eurjbiol.2022.1083922 · Cited by 1
Черновецкий, М. А., & Кондаурова, С. Л. (2022) · Лабораторная диагностика Восточная Европа · doi:10.34883/pi.2022.11.2.019 · Cited by 1
Pagliuca, A., & Akova, M. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac350
Wang, R., Jiang, A., Zhang, R., Shi, C., Ding, Q.-Q., Liu, S., Zhao, F., Ma, Y., Liu, J., Fu, X., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2486032/v1
Research and development status of antifungal drugs based on proteomics
Li, J., & Su, Y. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/23/20231038
Wang, J., He, X., Chen, F., Ma, X., Zeng, D., & Jiang, J. (2025) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2025.02.001
Challenges of diagnosis of hidden fungal infections as sequelae in post-coronavirus disease patients
Wijaya, M., Surja, S. S., Yolanda, H., Clarista, O., Joprang, F. S., & Kaisar, M. M. M. (2025) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000435
Evaluation of Mitis Salivarius Agar for fungal growth in comparison with three standard fungal media
Abed, A. B., Korcan, S. E., Titiz, S., & KÜÇÜK, G. K. (2026) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2026.107466
Antifungal activity of rezafungin in invasive candidiasis: From bench to bed
Quindós, G., García‐Vidal, C., Martin-Martitegui, X., & Zaragoza, R. (2026) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2026.02.001 · Cited by 1
Therapeutic Failure in Invasive Fungal Infections: Beyond Antifungal Resistance—A Narrative Review
Rivas-Pinedo, P., & Oñate, J. (2026) · Journal of Fungi · doi:10.3390/jof12080596 · Cited by 1
Jia, Q., Fan, A., Xie, X., Li, J., Zhang, L., & Yang, Q. (2026) · Journal of Fungi · doi:10.3390/jof12090692
“Furthermore, the sensitivity of fungal culture is variable and may be limited by specimen quality, fungal load, and prior antifungal exposure, and it can also lead to unreliable results due to contamination [11–14].”
Metadata
- Authors
- Jenks, J. D., Gangneux, J.-P., Schwartz, I. S., Alastruey-Izquierdo, A., Lagrou, K., Thompson III, G. R., Lass-Flörl, C., Hoenigl, M., & Investigators, E. C. O. M. M. (. C.
- Affiliations
- University of California San Diego (US)
- Inserm (FR)
- University of Alberta (CA)
- Mycology Reference Laboratory, National Centre for Microbiology. Instituto de Salud Carlos III. Majadahonda, 28222 Madrid, Spain
- Universitair Ziekenhuis Leuven (BE)
- Division of Infectious Diseases, Department of Internal Medicine and Department of Medical Microbiology and Immunology
- Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria
- Medical University of Graz (AT)
- Corresponding author
- Hoenigl, Martin
- ORCID
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2020-10-11
- Volume
- 6
- Issue
- 4
- Pages
- 216
- ISSN
- 2309-608X (ISSN-L)
- PMC
- PMC7712958
- OpenAlex
- W3081623395
- Cited by
- 44
- References
- 139
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 4 · 2023: 8 · 2022: 8 · 2021: 10 · 2020: 2
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Fungi (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, cc-by)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- IRIS (submittedVersion, cc-by)
- Lirias (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Pfizer
- Gilead Sciences
- Medpace
- Regeneron Pharmaceuticals
- Wellcome Trust (101873/A/13/Z)
- Cidara Therapeutics
- Mylan
- Amplyx
- Nabriva Therapeutics
- Deutsche Forschungsgemeinschaft (390661388, EXC2030)
- Astellas Pharma
- Shionogi
- Da Volterra
- Medical Research Council (MR/N006364/2)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- antifungal therapy, invasive mold infections, invasive aspergillosis, endemic mycoses, fungal culture, PCR-based assays, serologic tests, antifungal susceptibility testing, diagnostic recommendations, histopathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.